News & events
News
Aude Fahrer's work aims to activate the immune cells responsible for attacking cancer, in a simple, low cost way.
Alex Maier has been elected as a Fellow of the Australian Society for Parasitology.
They say leaders are born not made, but it seems the opposite is true for queen bees, according to a new study by researchers from The Australian National University (ANU) and Queen Mary University of London.
New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anaesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.
Linden Muellner-Wong has won a 2017 RSB Director's Prize in Honours.
Although significant advances in malaria control have been made in the past few decades, resistance to our current antimalarial drug repertoire threatens control efforts.
Events
A lipid bilayer is a vital component of the cell. It is selectively permeable, allowing only ions and organic molecules to pass through. Ions and solutes are transported by membrane transporters. Dysfunction of such proteins can lead to physiological disorders.
Discover the capabilities of the new Precision Fermentation Facility that has been established at RSB, including an overview of the equipment, its capabilities and potential applications.
Toxic accumulation of phenylalanine underlies the neurological deficits and morbidity in phenylketonuria (PKU). Despite availability of treatment options for PKU patients, high unmet need remains for safe and convenient therapies that work across a broad cross section of PKU patients and allow for diet normalization.
Regeneration is the natural ability to restore or replace damaged or lost body parts following severe injury. Regenerative abilities vary strongly across and within most bilaterian phyla.
DNA stability is a prerequisite in many of its applications, ranging from DNA-based vaccine, data storage to gene therapy. However, the existing strategies to enhance the DNA stability are ineffective and limited in scope.
Synthetic chemistry and synthetic biology offer complementary tools for manipulating the 3D architecture and function of biomolecules. I will outline two different projects that exemplify our hybrid chemical biology approach, highlighting divergent applications in catalysis and cancer therapy.